Literature DB >> 11398079

L-Selectin is required for the development of airway hyperresponsiveness but not airway inflammation in a murine model of asthma.

L C Fiscus1, J Van Herpen, D A Steeber, T F Tedder, M L Tang.   

Abstract

BACKGROUND: Airway inflammation and airway hyperresponsiveness (AHR) are fundamental features of asthma. Migration of inflammatory cells from the circulation into the lungs is dependent on adhesion molecule interactions. The cell surface adhesion molecule L-selectin has been demonstrated to mediate leukocyte rolling on inflamed and noninflamed pulmonary endothelium. However, its role in the development of airway inflammation and AHR in asthma has not been examined.
OBJECTIVE: We sought to characterize the role of L-selectin in the recruitment of inflammatory cells to the airway-lung and the development of AHR in a murine model of asthma.
METHODS: An ovalbumin (OVA)-induced allergic airway disease model of asthma was applied to L-selectin-deficient (LKO) mice and C57BL/6 wild-type (WT) control mice. The development of airway inflammation was assessed by examining leukocyte influx into bronchoalveolar lavage (BAL) fluid and the lung. Total and differential BAL leukocyte counts were determined, and the immunophenotype of BAL lymphocytes was assessed by means of flow cytometry. The development of AHR was assessed by means of whole-body plethysmography.
RESULTS: Airway-lung inflammation was equivalent in LKO and WT mice sensitized-challenged with OVA, as measured by total and differential BAL cell counts and histologic analysis of lung tissue. Numbers of eosinophils, neutrophils, lymphocytes, and monocytes in BAL fluid were equivalent in LKO and WT mice. However, phenotypic analysis of BAL lymphocytes demonstrated significantly reduced CD3(+) populations and increased B220(+) populations in LKO compared with WT mice (P <.05). Remarkably, despite a fulminant inflammatory response in the airway-lung in LKO mice sensitized-challenged with OVA, AHR was completely abrogated.
CONCLUSION: L-selectin plays a crucial role in the development of AHR but not allergic inflammation in an animal model of asthma. L-selectin represents a potential target for novel asthma therapies specifically aimed at controlling AHR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11398079     DOI: 10.1067/mai.2001.114703

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  13 in total

1.  Therapeutic targeting of endothelial ligands for L-selectin (PNAd) in a sheep model of asthma.

Authors:  Steven D Rosen; Durwin Tsay; Mark S Singer; Stefan Hemmerich; William M Abraham
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

2.  Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis.

Authors:  Yasuhito Hamaguchi; Yoriko Nishizawa; Masahide Yasui; Minoru Hasegawa; Yuko Kaburagi; Kazuhiro Komura; Tetsuya Nagaoka; Eriko Saito; Yuka Shimada; Kazuhiko Takehara; Takafumi Kadono; Douglas A Steeber; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Soluble L-Selectin as an Independent Biomarker of Bronchial Asthma.

Authors:  Ebrahim Nadi; Mehrdad Hajilooi; Saeed Pajouhan; Mehran Haidari
Journal:  J Clin Lab Anal       Date:  2014-05-05       Impact factor: 2.352

Review 4.  Defining the versican interactome in lung health and disease.

Authors:  Fengying Tang; Jourdan E Brune; Mary Y Chang; Stephen R Reeves; William A Altemeier; Charles W Frevert
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-01       Impact factor: 5.282

5.  Involvement of L-selectin in contact hypersensitivity responses augmented by auditory stress.

Authors:  Sang Jae Bae; Kazuhiro Shimizu; Mariko Yozaki; Toshifumi Yamaoka; Yuichiro Akiyama; Ayumi Yoshizaki; Eiji Muroi; Toshihide Hara; Fumihide Ogawa; Shinichi Sato
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

6.  Tumour necrosis factor-alpha blockade suppresses murine allergic airways inflammation.

Authors:  S Hutchison; B S W Choo-Kang; R V Bundick; A J Leishman; J M Brewer; I B McInnes; P Garside
Journal:  Clin Exp Immunol       Date:  2007-10-11       Impact factor: 4.330

7.  The contribution of L-selectin to airway hyperresponsiveness in chronic allergic airways disease.

Authors:  Simon G Royce; Melissa Lee; Mimi L K Tang
Journal:  J Asthma Allergy       Date:  2010-06-28

8.  The effect of CpG-oligodeoxynucleotides with different backbone structures and 3' hexameric deoxyriboguanosine run conjugation on the treatment of asthma in mice.

Authors:  Yoon-Seok Chang; Yoon-Keun Kim; Hyouk-Soo Kwon; Heung-Woo Park; Kyung-Up Min; You-Young Kim; Sang-Heon Cho
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

9.  Resveratrol has protective effects against airway remodeling and airway hyperreactivity in a murine model of allergic airways disease.

Authors:  Simon G Royce; William Dang; Gao Yuan; Jenny Tran; Assam El Osta; Tom C Karagiannis; Mimi L K Tang
Journal:  Pathobiol Aging Age Relat Dis       Date:  2011-06-01

10.  Identification of antigenic epitopes on human allergens: studies with HLA transgenic mice.

Authors:  Svetlana P Chapoval; Chella S David
Journal:  Environ Health Perspect       Date:  2003-02       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.